Get started
Biogen Inc. 3.25% 15-FEB-2051Biogen Inc. 3.25% 15-FEB-2051Biogen Inc. 3.25% 15-FEB-2051

Biogen Inc. 3.25% 15-FEB-2051

No trades
See on Supercharts
Overview
Analysis News

BIIB5133378 chart


Full chart

Key terms


Outstanding amount
‪700.71 M‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
3.25% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
6.88%
Maturity date
Feb 15, 2051
Term to maturity
26 years

About Biogen Inc. 3.25% 15-FEB-2051


Issuer
Biogen, Inc.
Sector
Health Technology
Home page
biogen.com
Issue date
Jun 28, 2022
FIGI
BBG017V5GP77
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

BIIB5133378 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

BIIB5133378 news